par Morgane Le Cam
Geneva Solutions is a new journalistic platform dedicated to covering Genève internationale. We will be launching our website (genevasolutions.news) along with a daily newsletter in August 2020, covering daily news on Peace & Humanitarian, Climate , Global Health, Sustainable Business & Finance, and Technology. In the midst of the Coronavirus pandemic we have opted for an early-release of our Global Health news stream, which starting April 2020 provides insights into how the institutions and people in Geneva are responding to this crisis.
Sortir de la crise, la newsletter qui aborde les enjeux de la sortie de crise selon une thématique différente
Nos lectrices et lecteursLire les témoignages
Last week, a report published in The BMJ slammed European drug regulations for allowing biopharmaceuticals to reap "billions" in profits on new drugs for rare diseases, but failing to incentivize sufficient R&D into new cures and treatments. A leading patient advocacy group, however, says that while the regulations may be in need of reform, they have helped advance treatments for many debilitating and deadly rare diseases.
Here at Geneva Solutions, we're tackling the news from a constructive angle. As we’re about to launch on August 24, we'd like to share with you some information and insights on our approach.
Recevez chaque matin un résumé de l'actualité envoyé d'une ville différente du monde.